Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

25.8K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.8K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.4K
5.4K
RNA Splicing01:32

RNA Splicing

61.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.1K
RNA Splicing01:32

RNA Splicing

19.9K
19.9K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

1.5K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.5K
Homologous Recombination02:31

Homologous Recombination

65.0K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Characteristics of Cardiac Arrhythmia in Duchenne Muscular Dystrophy: A Retrospective, Single-Center Holter Electrocardiographic Monitoring Study.

European journal of neurology·2026
Same author

Transcript Imbalance from TENM4 Exon Skipping: Effects on Epilepsy and Genetic Pleiotropy.

Molecular neurobiology·2025
Same author

Reply to Letter to the Editor regarding the article "SCN1A gain of function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications".

Epilepsia open·2025
Same author

Reply to the "letter to the editor: 'Prevalence and management of gastrointestinal complications of Duchenne muscular dystrophy: A retrospective cohort study'".

Brain & development·2025
Same author

Natural history of timed rise from floor in young individuals with Duchenne muscular dystrophy: A single-center retrospective study.

Brain & development·2025
Same author

Prevalence and management of gastrointestinal complications in Duchenne muscular dystrophy: A retrospective cohort study.

Brain & development·2025
Same journal

LncRNA EGOT inhibits the proliferation of lung adenocarcinoma cells and is associated with poor prognosis.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Can the combination of 5-fluorouracil and gemcitabine increase the treatment efficacy of pancreatic and colon cancer?

Nucleosides, nucleotides & nucleic acids·2026
Same journal

"Aptamer-guided therapeutics and diagnostics for metabolic syndrome: Design, delivery, and translation of aptamer-based systems".

Nucleosides, nucleotides & nucleic acids·2026
Same journal

The impact of vitamin B12 deficiency on urinary profile of <i>de novo</i> purine synthesis intermediates: consequences of the methylfolate trap.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Evaluation of MTH1 and DCTPP1 inhibitors in fluorocyclopentenylcytosine (RX-3117) resistant lung cancer cells and potential cross resistance patterns.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Circular RNAs: promising biomarkers for diagnosis, prognosis and therapy in oral squamous cell carcinoma.

Nucleosides, nucleotides & nucleic acids·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast
08:48

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast

Published on: January 26, 2017

16.5K

Novel mutation in HPRT1 causing a splicing error with multiple variations.

Shimpei Baba1, Takashi Saito1, Yasukazu Yamada2

  • 1a Department of Child Neurology , National Center Hospital, National Center of Neurology and Psychiatry (NCNP) , Tokyo , Japan.

Nucleosides, Nucleotides & Nucleic Acids
|October 19, 2016
PubMed
Summary
This summary is machine-generated.

Lesch-Nyhan disease (LND) is a rare genetic disorder. A new duplication mutation in the HPRT1 gene causing splicing errors was identified in a patient with LND symptoms.

Keywords:
DuplicationHPRTLesch-Nyhan diseasemutationsplicing error

More Related Videos

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.3K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K

Related Experiment Videos

Last Updated: Mar 13, 2026

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast
08:48

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast

Published on: January 26, 2017

16.5K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.3K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K

Area of Science:

  • Genetics
  • Biochemistry
  • Neurology

Background:

  • Lesch-Nyhan disease (LND) is a rare X-linked recessive disorder.
  • It results from deficiency of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme, encoded by the HPRT1 gene.
  • While various HPRT1 mutations are known, duplication mutations are exceptionally rare.

Observation:

  • A 9-month-old boy presented with LND symptoms including developmental delay, athetosis, and dystonic posture.
  • The patient exhibited hyperuricemia and complete deficiency of HPRT enzyme activity in erythrocytes.
  • Notably, the patient did not display self-injurious behaviors, a common LND manifestation.

Findings:

  • A novel duplication mutation (c.372dupT, c.372_374 TTT > c.372_375 TTTT) was identified in exon 4 of the HPRT1 gene.
  • This mutation was found to cause aberrant splicing of the HPRT1 gene.
  • This represents the third reported case of a duplication mutation in HPRT1 leading to splicing errors.

Implications:

  • This case expands the known spectrum of HPRT1 mutations causing LND.
  • Understanding novel mutations like this duplication is crucial for accurate genetic diagnosis and counseling.
  • Further research into HPRT1 splicing defects may reveal new therapeutic targets for LND.